Search research articles
Contact Us
Filters
Showing results (371-380 of 387) with videos related to
Page
of 39
Sort By:
The Lancet. Oncology
|
February 4, 2018
Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study
Giuseppe Giaccone, Chul Kim, Jillian Thompson, et al.
Cell
|
January 12, 2021
A modular master regulator landscape controls cancer transcriptional identity
Evan O Paull, Alvaro Aytes, Sunny J Jones, et al.
Cancer Cell
|
April 21, 2012
Targeting nonclassical oncogenes for therapy in T-ALL
Prem S Subramaniam, Dosh W Whye, Evgeni Efimenko, et al.
British Journal of Cancer
|
March 13, 2018
A phase 1 dose-escalation study of veliparib with bimonthly FOLFIRI in patients with advanced solid tumours
Jordan Berlin, Ramesh K Ramanathan, John H Strickler, et al.
Ferroptosis and Oxidative Stress
|
December 29, 2025
Lipidomic changes in persister cancer cells drive enhanced ferroptosis sensitivity
Eduard Reznik, Fereshteh Zandkarimi, Joleen M Csuka, et al.
The FEBS Journal
|
December 28, 2017
A high parasite density environment induces transcriptional changes and cell death in Plasmodium falciparum blood stages
Evelyn S Chou, Sabia Z Abidi, Marian Teye, et al.
Journal of Medicinal Chemistry
|
May 30, 1998
Novel euglycemic and hypolipidemic agents. 1
B B Lohray, V Bhushan, B P Rao, et al.
Transboundary and Emerging Diseases
|
March 3, 2017
Quantitative characteristics of the foot-and-mouth disease carrier state under natural conditions in India
S S Hayer, R Ranjan, J K Biswal, et al.
Transboundary and Emerging Diseases
|
December 9, 2014
Outbreaks of Foot-and-Mouth Disease in Libya and Saudi Arabia During 2013 Due to an Exotic O/ME-SA/Ind-2001 Lineage Virus
N J Knowles, K Bachanek-Bankowska, J Wadsworth, et al.
EJNMMI Research
|
January 20, 2017
A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB-IIIA resectable NSCLC
John P Crandall, Abdel K Tahari, Rosalyn A Juergens, et al.
Page
of 39
Search research articles
Search
Showing results (371-380 of 387) with videos related to
Sort By:
Page
of 39
The Lancet. Oncology
|
February 4, 2018
Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study
Giuseppe Giaccone, Chul Kim, Jillian Thompson, et al.
Cell
|
January 12, 2021
A modular master regulator landscape controls cancer transcriptional identity
Evan O Paull, Alvaro Aytes, Sunny J Jones, et al.
Cancer Cell
|
April 21, 2012
Targeting nonclassical oncogenes for therapy in T-ALL
Prem S Subramaniam, Dosh W Whye, Evgeni Efimenko, et al.
British Journal of Cancer
|
March 13, 2018
A phase 1 dose-escalation study of veliparib with bimonthly FOLFIRI in patients with advanced solid tumours
Jordan Berlin, Ramesh K Ramanathan, John H Strickler, et al.
Ferroptosis and Oxidative Stress
|
December 29, 2025
Lipidomic changes in persister cancer cells drive enhanced ferroptosis sensitivity
Eduard Reznik, Fereshteh Zandkarimi, Joleen M Csuka, et al.
The FEBS Journal
|
December 28, 2017
A high parasite density environment induces transcriptional changes and cell death in Plasmodium falciparum blood stages
Evelyn S Chou, Sabia Z Abidi, Marian Teye, et al.
Journal of Medicinal Chemistry
|
May 30, 1998
Novel euglycemic and hypolipidemic agents. 1
B B Lohray, V Bhushan, B P Rao, et al.
Transboundary and Emerging Diseases
|
March 3, 2017
Quantitative characteristics of the foot-and-mouth disease carrier state under natural conditions in India
S S Hayer, R Ranjan, J K Biswal, et al.
Transboundary and Emerging Diseases
|
December 9, 2014
Outbreaks of Foot-and-Mouth Disease in Libya and Saudi Arabia During 2013 Due to an Exotic O/ME-SA/Ind-2001 Lineage Virus
N J Knowles, K Bachanek-Bankowska, J Wadsworth, et al.
EJNMMI Research
|
January 20, 2017
A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB-IIIA resectable NSCLC
John P Crandall, Abdel K Tahari, Rosalyn A Juergens, et al.
Page
of 39